Drug class · Neurology & psychiatry
Anti-epileptic agents Drug Codes & NDCs
Drugs in the FDA's anti-epileptic class, in oral and injectable forms.
Most-listed names in this class
Ranked by the number of FDA listings, which reflects labelers and package variety — not sales or prescribing.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Celontinmethsuximide | Methsuximide 300 mg/1 | CapsuleOral | Parke-Davis Div of Pfizer Inc | 0071-0525 |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | 0069-5471 |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | 0069-5474 |
| Cerebyxfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | Pfizer Laboratories Div Pfizer Inc | 0069-6001 |
| Depakotedivalproex sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | AbbVie Inc. | 0074-7325 |
| Depakotedivalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | AbbVie Inc. | 0074-7326 |
| Depakotedivalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | AbbVie Inc. | 0074-7327 |
| Depakote ERdivalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Extended releaseOral | AbbVie Inc. | 0074-7401 |
| Depakote ERdivalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | AbbVie Inc. | 0074-7402 |
| Depakote Sprinklesdivalproex sodium | Divalproex sodium 125 mg/1 | CapsuleOral | AbbVie Inc. | 0074-6114 |
| Dilantinextended phenytoin sodium | Phenytoin sodium 100 mg/1 | Capsule, Extended releaseOral | Viatris Specialty LLC | 58151-110 |
| Dilantinextended phenytoin sodium | Phenytoin sodium 30 mg/1 | Capsule, Extended releaseOral | Viatris Specialty LLC | 58151-118 |
| Dilantinextended phenytoin sodium | Phenytoin sodium 30 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4325 |
| Dilantin Infatabsphenytoin | Phenytoin 50 mg/1 | Tablet, ChewableOral | Parke-Davis Div of Pfizer Inc | 0071-0007 |
| Dilantin-125phenytoin | Phenytoin 125 mg/5mL | SuspensionOral | Viatris Specialty LLC | 58151-115 |
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Film coated, Extended releaseOral | Mylan Pharmaceuticals Inc. | 0378-0472 |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Film coated, Extended releaseOral | Mylan Pharmaceuticals Inc. | 0378-0473 |
| Divalproex sodium | Divalproex sodium 125 mg/1 | CapsuleOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8237 |
| Divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8376 |
| Divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8377 |
| divalproex sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8586 |
| divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8587 |
| divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8588 |
| Divalproex Sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | Upsher-Smith Laboratories, LLC | 0832-7122 |
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | Upsher-Smith Laboratories, LLC | 0832-7123 |